Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Warfarin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VKORC1 known ✓ | Q9BQB6 | 3/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 10/20 | 1.00 |
| ▸ | ALB | P02768 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | PCSK7 | Q16549 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.77 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.77 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | BRD4 | O60885 | 1/20 | 0.68 |
| ▸ | NQO1 | P15559 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Warfarin SCHEMBL29400364 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL3689 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL662875 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL2139452 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL4439794 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL4757598 | 0.99 | CYP2C9 (0.97) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL34347 | 0.99 | CYP2C9 (0.97) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL2597774 | 0.99 | CYP2C9 (0.97) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL13278154 | 0.99 | CYP2C9 (0.97) | CYP2C9VKORC1ALBHSD17B10KDM4E | |
| Warfarin SCHEMBL5016404 | 0.99 | CYP2C9 (0.97) | CYP2C9VKORC1ALBHSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025101983-A1 | NON-STEROIDAL ISONITRILE BINDING COMPOUNDS OF CYTOCHROME P450 SUBTYPES | BRANDEIS UNIVERSITY (US) | 2025-05-15 | — | — | WO | claimed |
| CN-119541900-A | Evaluation method for influence of traditional Chinese medicine on warfarin anticoagulation effect based on PK/PD theory | 哈尔滨医科大学 | 2025-02-28 | — | — | CN | claimed |
| US-20240100126-A1 | Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug | I2O THERAPEUTICS INC (US) | 2024-03-28 | — | — | US | claimed |
| WO-2022036444-A1 | ATTRACTANT BLEND COMPOSITION COMPRISING 2,3,5-TRITHIAHEXANE, 1-HEXANOL AND/OR 3-METHYL-2-PENTANONE, AND DEVICES AND METHODS FOR ATTRACTING FEMALE MICE | GRIES GERHARD (CA) | 2022-02-24 | — | — | WO | claimed |
| EP-4682237-A2 | SYSTEM FOR FUNCTIONAL TESTING AND TRANSPORTATION OF BIOLOGICALLY ENGINEERED ORGANS | Miromatrix Medical Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-3896148-B1 | SYSTEM FOR FUNCTIONAL TESTING AND TRANSPORTATION OF BIOLOGICALLY ENGINEERED ORGANS | MIROMATRIX MEDICAL INC (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250228236-A1 | EXTRACORPOREAL ORGAN SUPPORT SYSTEM | MIROMATRIX MEDICAL INC. | 2025-07-17 | — | — | US | disclosed |
| EP-3443338-B1 | METHODS FOR DETECTION OF SAMPLE ENANTIOMERS USING DIFFERENTIAL MOBILITY SPECTROMETRY | DH TECHNOLOGIES DEV PTE LTD (SG) | 2025-07-09 | — | — | EP | disclosed |
| WO-2025137586-A2 | COMPOSITIONS, METHODS, AND SYSTEMS FOR PROMOTING PHOSPHATE SOLUBILIZATION IN PLANTS | Tenfold Technologies, LLC (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025101983-A1 | NON-STEROIDAL ISONITRILE BINDING COMPOUNDS OF CYTOCHROME P450 SUBTYPES | BRANDEIS UNIVERSITY (US) | 2025-05-15 | — | — | WO | disclosed |
| EP-3462875-B1 | DEVICE FOR ATTRACTING A RODENT | GRIES GERHARD J (CA) | 2025-05-07 | — | — | EP | disclosed |
| CN-119541900-A | Evaluation method for influence of traditional Chinese medicine on warfarin anticoagulation effect based on PK/PD theory | 哈尔滨医科大学 | 2025-02-28 | — | — | CN | disclosed |
| WO-2023069939-A1 | SYSTEM FOR SUPPORTING BIOLOGICALLY ENGINEERED ORGANS | MIROMATRIX MEDICAL INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023069930-A1 | EXTRACORPOREAL ORGAN SUPPORT SYSTEM | MIROMATRIX MEDICAL INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| US-20220233633-A1 | ORAL OCTREOTIDE THERAPY AND CONTRACEPTIVE METHODS | AMRYT PHARMACEUTICALS INC. | 2022-07-28 | — | — | US | disclosed |
| EP-3981442-A1 | MOBILE DEVICE OPERABLE BY MEANS OF A TEMPERATURE DIFFERENCE FOR CLEANING AND DISINFECTING ROOM AIR | Münch, Elke (DE) | 2022-04-13 | — | — | EP | disclosed |
| EP-3978038-A1 | MOBILE DEVICE OPERABLE BY MEANS OF A TEMPERATURE DIFFERENCE FOR CLEANING AND DISINFECTING ROOM AIR AND TEST DEVICE FOR SAME | Münch, Elke (DE) | 2022-04-06 | — | — | EP | disclosed |
| US-20100273203-A1 | METHODS AND COMPOSITIONS FOR DETECTING METABOLITES | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2010-10-28 | — | — | US | disclosed |
| US-5856525-A | ANTICOAGULANTS; RACEMIC MIXTURE OF S AND R-WARFARIN | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-01-05 | — | — | US | disclosed |
| US-5686631-A | OXIDATION OF RACEMATE, STEREOSPECIFIC HYDROGENATION WITH CHIRAL PHOSPHINE CATALYST | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-11-11 | — | — | US | disclosed |